scispace - formally typeset
J

Jason Ellul

Researcher at Peter MacCallum Cancer Centre

Publications -  23
Citations -  2343

Jason Ellul is an academic researcher from Peter MacCallum Cancer Centre. The author has contributed to research in topics: Regulation of gene expression & Exome. The author has an hindex of 16, co-authored 22 publications receiving 1904 citations. Previous affiliations of Jason Ellul include University of Melbourne.

Papers
More filters
Journal ArticleDOI

Whole-genome characterization of chemoresistant ovarian cancer

Ann-Marie Patch, +99 more
- 28 May 2015 - 
TL;DR: It is shown that gene breakage commonly inactivates the tumour suppressors RB1, NF1, RAD51B and PTEN in HGSC, and contributes to acquired chemotherapy resistance.
Journal ArticleDOI

Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.

TL;DR: These findings indicate that DNA damage following formalin fixation remains a major challenge in laboratories working with MPS, and methodologies that assess, minimise or remove formalin-induced DNA damaged templates as part of MPS protocols will aid in the interpretation of genomic results leading to better patient outcomes.
Journal ArticleDOI

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.

TL;DR: The data demonstrate the utility of intra-family exome-sequencing approaches to uncover cancer predisposing genes, but highlight the major challenge of definitively validating candidates where the incidence of sporadic disease is high, germline mutations are not fully penetrant, and individual predisposition genes may only account for a tiny proportion of breast cancer families.
Journal ArticleDOI

c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation

TL;DR: In this paper, the authors demonstrate a robust reduction of loading onto rDNA that along with a depletion of the MYC target gene upstream binding factor (UBF) and a switch from epigenetically active to silent rDNA accompanies this MYC reduction.